Peptide splicing in the proteasome creates a novel type of antigen with an isopeptide linkage

Journal of Immunology

Volumn 195, Issue 9, 2015, Pages 4075-4084

  Berkers, Celia R ^a,c,d   De Jong, Annemieke ^a   Schuurman, Karianne G ^a   Linnemann, Carsten ^a   Geenevasen, Jan A J ^b   Schumacher, Ton N M ^a,c   Rodenko, Boris ^a   Ovaa, Huib ^a,c  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Institute for Chemical Immunology   (Netherlands)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA A3 ANTIGEN; LYSINE; PROTEASOME; ISOPROTEIN; PEPTIDE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CD8+ T LYMPHOCYTE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVE SITE; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; CHEMISTRY; HUMAN; IMMUNOLOGY; PROTEIN SPLICING; T LYMPHOCYTE;

HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN SPLICING; T-LYMPHOCYTES;

EID: 84945156310     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402454     Document Type: Article

References (36)

1. Schmidt, M., and D. Finley. 2014. Regulation of proteasome activity in health and disease. Biochim. Biophys. Acta 1843: 13-25.
2. Sijts, E. J., and P. M. Kloetzel. 2011. The role of the proteasome in the generation of MHC class I ligands and immune responses. Cell. Mol. Life Sci. 68: 1491-1502.
3. Vigneron, N., and B. J. Van den Eynde. 2012. Proteasome subtypes and the processing of tumor antigens: increasing antigenic diversity. Curr. Opin. Immunol. 24: 84-91.
4. Basler, M., C. J. Kirk, and M. Groettrup. 2013. The immunoproteasome in antigen processing and other immunological functions. Curr. Opin. Immunol. 25: 74-80.
5. Vigneron, N., V. Stroobant, J. Chapiro, A. Ooms, G. Degiovanni, S. Morel, P. van der Bruggen, T. Boon, and B. J. Van den Eynde. 2004. An antigenic peptide produced by peptide splicing in the proteasome. Science 304: 587-590.
6. Hanada, K., J. W. Yewdell, and J. C. Yang. 2004. Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427: 252-256.
7. Warren, E. H., N. J. Vigneron, M. A. Gavin, P. G. Coulie, V. Stroobant, A. Dalet, S. S. Tykodi, S. M. Xuereb, J. K. Mito, S. R. Riddell, and B. J. Van den Eynde. 2006. An antigen produced by splicing of noncontiguous peptides in the reverse order. Science 313: 1444-1447.
8. Dalet, A., P. F. Robbins, V. Stroobant, N. Vigneron, Y. F. Li, M. El-Gamil, K. Hanada, J. C. Yang, S. A. Rosenberg, and B. J. Van den Eynde. 2011. An antigenic peptide produced by reverse splicing and double asparagine deamidation. Proc. Natl. Acad. Sci. USA 108: E323-E331.
9. Michaux, A., P. Larrieu, V. Stroobant, J. F. Fonteneau, F. Jotereau, B. J. Van den Eynde, A. Moreau-Aubry, and N. Vigneron. 2014. A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming. J. Immunol. 192: 1962-1971.
10. Borissenko, L., and M. Groll. 2007. Diversity of proteasomal missions: fine tuning of the immune response. Biol. Chem. 388: 947-955.
11. Shastri, N. 2006. Cell biology. Peptides, scrambled and stitched. Science 313: 1398-1399.
12. Berkers, C. R., A. de Jong, H. Ovaa, and B. Rodenko. 2009. Transpeptidation and reverse proteolysis and their consequences for immunity. Int. J. Biochem. Cell Biol. 41: 66-71.
13. Dalet, A., N. Vigneron, V. Stroobant, K. Hanada, and B. J. Van den Eynde. 2010. Splicing of distant peptide fragments occurs in the proteasome by transpeptidation and produces the spliced antigenic peptide derived from fibroblast growth factor-5. J. Immunol. 184: 3016-3024.
14. Mishto, M., A. Goede, K. T. Taube, C. Keller, K. Janek, P. Henklein, A. Niewienda, A. Kloss, S. Gohlke, B. Dahlmann, et al. 2012. Driving forces of proteasome-catalyzed peptide splicing in yeast and humans. Mol. Cell. Proteomics 11: 1008-1023.
15. Liepe, J., M. Mishto, K. Textoris-Taube, K. Janek, C. Keller, P. Henklein, P. M. Kloetzel, and A. Zaikin. 2010. The 20S proteasome splicing activity discovered by SpliceMet. PLOS Comput. Biol. 6: e1000830.
16. Berkers, C. R., A. de Jong, K. G. Schuurman, C. Linnemann, H. D. Meiring, L. Janssen, J. J. Neefjes, T. N. M. Schumacher, B. Rodenko, and H. Ovaa. 2015. Definition of proteasomal peptide splicing rules for high efficiency spliced peptide presentation by MHC class I molecules. J. Immunol. 195: 4085-4095.
17. Wiejak, S., E. Masiukiewicz, and B. Rzeszotarska. 1999. A large scale synthesis of mono- and di-urethane derivatives of lysine. Chem. Pharm. Bull. (Tokyo) 47: 1489-1490.
18. Raijmakers, R., C. R. Berkers, A. de Jong, H. Ovaa, A. J. Heck, and S. Mohammed. 2008. Automated online sequential isotope labeling for protein quantitation applied to proteasome tissue-specific diversity. Mol. Cell. Proteomics 7: 1755-1762.
19. Berkers, C. R., F. W. van Leeuwen, T. A. Groothuis, V. Peperzak, E. W. van Tilburg, J. Borst, J. J. Neefjes, and H. Ovaa. 2007. Profiling proteasome activity in tissue with fluorescent probes. Mol. Pharm. 4: 739-748.
20. de Jong, A., K. G. Schuurman, B. Rodenko, H. Ovaa, and C. R. Berkers. 2012. Fluorescence-based proteasome activity profiling. Methods Mol. Biol. 803: 183-204.
21. Boyd, J., N. Soffe, B. John, D. Plant, and R. Hurd. 1992. The generation of phase-sensitive 2D N-15-H-1 spectra using gradient pulses for coherencetransfer-pathway selection. J. Magn. Reson. 98: 660-664.
22. Davis, A., J. Keeler, E. Laue, and D. Moskau. 1992. Experiments for recording pure-absorption heteronuclear correlation spectra using pulsed field gradients. J. Magn. Reson. 98: 207-216.
23. Rodenko, B., M. Toebes, P. H. Celie, A. Perrakis, T. N. Schumacher, and H. Ovaa. 2009. Class I major histocompatibility complexes loaded by a periodate trigger. J. Am. Chem. Soc. 131: 12305-12313.
24. Bakker, A. H., R. Hoppes, C. Linnemann, M. Toebes, B. Rodenko, C. R. Berkers, S. R. Hadrup, W. J. van Esch, M. H. Heemskerk, H. Ovaa, and T. N. Schumacher. 2008. Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7. Proc. Natl. Acad. Sci. USA 105: 3825-3830.
25. Toebes, M., B. Rodenko, H. Ovaa, and T. N. Schumacher. 2009. Generation of peptide MHC class I monomers and multimers through ligand exchange. Curr. Protoc. Immunol. Chapter 18: Unit 18.16. doi:10.1002/0471142735.im1816s87
26. Hadrup, S. R., A. H. Bakker, C. J. Shu, R. S. Andersen, J. van Veluw, P. Hombrink, E. Castermans, P. Thor Straten, C. Blank, J. B. Haanen, et al. 2009. Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers. Nat. Methods 6: 520-526.
27. Lightcap, E. S., T. A. McCormack, C. S. Pien, V. Chau, J. Adams, and P. J. Elliott. 2000. Proteasome inhibition measurements: clinical application. Clin. Chem. 46: 673-683.
28. Chauhan, D., L. Catley, G. Li, K. Podar, T. Hideshima, M. Velankar, C. Mitsiades, N. Mitsiades, H. Yasui, A. Letai, et al. 2005. A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from bortezomib. Cancer Cell 8: 407-419.
29. Berkers, C. R., Y. Leestemaker, K. G. Schuurman, B. Ruggeri, S. Jones-Bolin, M. Williams, and H. Ovaa. 2012. Probing the specificity and activity profiles of the proteasome inhibitors bortezomib and delanzomib. Mol. Pharm. 9: 1126-1135.
30. Marek, R., and A. Lycka. 2002. 15N NMR spectroscopy in structural analysis. Curr. Org. Chem. 6: 35-66.
31. 15N transverse relaxation. J. Am. Chem. Soc. 129: 2971-2980.
32. 15N-enriched human ubiquitin resulting from relaxation interference and residual dipolar coupling. J. Am. Chem. Soc. 118: 6264-6272.
33. Kang, H. J., F. Coulibaly, F. Clow, T. Proft, and E. N. Baker. 2007. Stabilizing isopeptide bonds revealed in Gram-positive bacterial pilus structure. Science 318: 1625-1628.
34. Falk, K., O. Rötzschke, S. Stevanović, G. Jung, and H. G. Rammensee. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290-296.
35. Solache, A., C. L. Morgan, A. I. Dodi, C. Morte, I. Scott, C. Baboonian, B. Zal, J. Goldman, J. E. Grundy, and J. A. Madrigal. 1999. Identification of three HLA-A∗0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. J. Immunol. 163: 5512-5518.
36. Toebes, M., M. Coccoris, A. Bins, B. Rodenko, R. Gomez, N. J. Nieuwkoop, W. van de Kasteele, G. F. Rimmelzwaan, J. B. Haanen, H. Ovaa, and T. N. Schumacher. 2006. Design and use of conditional MHC class I ligands. Nat. Med. 12: 246-251.